483 854

Cited 0 times in

신장 이식 수술 후 골밀도 변화와 이에 영향을 미치는 인자

Other Titles
 Change of Bone Mineral Density after Kidney Transplantation and Factors Influencing Post- transplant Bone Mineral Density Loss 
 김현정  ;  김명수  ;  김유선  ;  지선하  ;  안형준  ;  허규하  ;  전경옥  ;  김순일 
 JOURNAL OF THE KOREAN SURGICAL SOCIETY , Vol.69(4) : 315-321, 2005 
Journal Title
Issue Date
Purpose: Osteoporosis is one of the common complications following kidney transplantation which causes profound morbidity. Using the pre-transplant bone mineral density (BMD) data, post-transplant change in the BMD of recipients was retrospectively evaluated. The risk factors affecting the post-transplant BMD changes were also evaluated in this study.
Methods: Between Jan. 1996 and Sep. 2003, 294 kidney transplant recipients were enrolled in this study. The BMD was expressed as the T-score of the spine and femur. The gender, age, the presence of pre-transplant diabetes mellitus, the matching degree of ABO blood types, the mode and duration of dialysis, and the history of previous transplantation were considered as variables possibly affecting the pre-transplant BMD and post-transplant BMD loss. Comparison analysis in each group was performed by a Students t-test or ANOVA.
Results: According to the pre-transplant BMD study, the mean of the spine T-score was significantly lower in the retransplant group. The mean femur T-score was also significantly lower in the retransplant group as well as the elderly (more than 45 years) and female recipients. In the 3 years following transplantation, rapid bone loss occurred particularly in the first post-transplant year. After a kidney transplantation, the normal pre-transplant BMD group (T- score>⁣1.0) showed a significantly higher bone loss than the abnormal pre-transplant BMD group (T-score≤⁣1.0). Prolonged pre-transplant hemodialysis (more than 12 months) and a retransplant were risk factors affecting the BMD loss in the first post-transplant year. The early application of anti-osteoporosis management (such as alfacalcidol, alendronate sodium, or risendronate sodium) was effective in ameliorating the post-transplant BMD loss. However, anti- osteoporosis management after the first post- transplant year was not effective.
Conclusion: A pre-transplant evaluation of the BMD and the significant BMD loss during the first post-transplant year should not be overlooked. Prophylactic management against the bone loss and the treatment of osteoporosis should be started as soon as possible after transplantation in recipients with both normal and abnormal pre-transplant BMD.
Files in This Item:
T200501428.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
4. Graduate School of Public Health (보건대학원) > Graduate School of Public Health (보건대학원) > 1. Journal Papers
Yonsei Authors
Kim, Myoung Soo(김명수) ORCID logo https://orcid.org/0000-0002-8975-8381
Kim, Soon Il(김순일) ORCID logo https://orcid.org/0000-0002-0783-7538
Kim, Yu Seun(김유선) ORCID logo https://orcid.org/0000-0002-5105-1567
Ahn, Hyung Joon(안형준)
Jee, Sun Ha(지선하) ORCID logo https://orcid.org/0000-0001-9519-3068
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.